Tacrolimus exposure windows responsible for Listeria monocytogenes infection susceptibility
- 22 June 2021
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4) , e13655
Abstract
Tacrolimus is widely used to prevent graft rejection after allogeneic transplantation by suppressing T cells in a non‐antigen‐specific fashion. Global T‐cell suppression makes transplant recipients more susceptible to infection, especially infection by opportunistic intracellular pathogens. Infection followed by secondary challenge with the opportunistic intracellular bacterial pathogen, Listeria monocytogenes, was used to probe when tacrolimus most significantly impacts antimicrobial host defense. Tacrolimus‐treated mice showed no difference in innate susceptibility following primary infection, whereas susceptibility to secondary challenge was significantly increased. Modifying the timing of tacrolimus initiation with respect to primary infection compared with secondary challenge showed significantly reduced susceptibility in tacrolimus‐treated mice where tacrolimus was discontinued prior to secondary challenge. Thus, tacrolimus overrides protection against secondary infection primed by primary infection (and presumably live attenuated vaccines), with the most critical window for tacrolimus‐induced infection susceptibility being exposure immediately prior to secondary challenge. These results have important implications for strategies designed to boost antimicrobial T‐cell‐mediated immunity in transplant recipients.Keywords
Funding Information
- National Institutes of Health (DP1AI131080, R01AI120202, R01AI124657)
- Howard Hughes Medical Institute
- Burroughs Wellcome Fund
This publication has 28 references indexed in Scilit:
- Serologic Vaccination Response after Solid Organ Transplantation: A Systematic ReviewPLOS ONE, 2013
- Ly6G+ Neutrophils Are Dispensable for Defense against Systemic Listeria monocytogenes InfectionThe Journal of Immunology, 2011
- Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantationJournal of Experimental Medicine, 2010
- Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus ConferenceTherapeutic Drug Monitoring, 2009
- Varicella Zoster Virus Serostatus Before and After Kidney Transplantation, and Vaccination of Adult Kidney Transplant CandidatesTransplantation Proceedings, 2006
- Immunosuppressive Drugs for Kidney TransplantationNew England Journal of Medicine, 2004
- Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and ProtocolsClinical Microbiology Reviews, 2003
- Specific immunity to listeria monocytogenes in the absence of IFNγImmunity, 1995
- Failure of FK 506 to suppress the T cell-mediated immunity of mice toListeria monocytogenesClinical and Experimental Immunology, 1993
- Clinical Presentation and Outcome of Listeriosis in Patients with and without Immunosuppressive TherapyClinical Infectious Diseases, 1992